These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 17682106

  • 1. Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
    Hocquet D, Berthelot P, Roussel-Delvallez M, Favre R, Jeannot K, Bajolet O, Marty N, Grattard F, Mariani-Kurkdjian P, Bingen E, Husson MO, Couetdic G, Plésiat P.
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3531-6. PubMed ID: 17682106
    [Abstract] [Full Text] [Related]

  • 2. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C, Pourcel C, Richardot C, Plésiat P, Fichant G, Cavallo JD, Mérens A, GERPA Study Group.
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [Abstract] [Full Text] [Related]

  • 3. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.
    Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD.
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):43-50. PubMed ID: 15380277
    [Abstract] [Full Text] [Related]

  • 4. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ, Black JA, Lister PD, Hanson ND.
    J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
    [Abstract] [Full Text] [Related]

  • 5. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
    Lee JY, Ko KS.
    Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J, Zhou JY, Qu TT, Shen P, Wei ZQ, Yu YS, Li LJ.
    Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
    [Abstract] [Full Text] [Related]

  • 9. Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone.
    Hocquet D, Bertrand X, Köhler T, Talon D, Plésiat P.
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1887-94. PubMed ID: 12760863
    [Abstract] [Full Text] [Related]

  • 10. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Aghazadeh M, Hojabri Z, Mahdian R, Nahaei MR, Rahmati M, Hojabri T, Pirzadeh T, Pajand O.
    Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN, Clark RB, Karlowsky JA, Ramirez J, Bordon JM.
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [Abstract] [Full Text] [Related]

  • 14. Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa.
    Dupont P, Hocquet D, Jeannot K, Chavanet P, Plésiat P.
    J Antimicrob Chemother; 2005 Apr; 55(4):518-22. PubMed ID: 15722391
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates.
    Pai H, Kim J, Kim J, Lee JH, Choe KW, Gotoh N.
    Antimicrob Agents Chemother; 2001 Feb; 45(2):480-4. PubMed ID: 11158744
    [Abstract] [Full Text] [Related]

  • 17. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa.
    Tam VH, Chang KT, LaRocco MT, Schilling AN, McCauley SK, Poole K, Garey KW.
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):309-14. PubMed ID: 17617302
    [Abstract] [Full Text] [Related]

  • 18. [Low-level resistance to fluoroquinolones conferred by efflux overproduction in Pseudomonas aeruginosa: clinical significance and routine detection].
    Hocquet D, Patry I, Dupont P, Bize M, Jeannot K, Chavanet P, Plésiat P.
    Pathol Biol (Paris); 2005 Jul; 53(8-9):495-9. PubMed ID: 16203109
    [Abstract] [Full Text] [Related]

  • 19. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B.
    APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
    [Abstract] [Full Text] [Related]

  • 20. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
    Goli HR, Nahaei MR, Rezaee MA, Hasani A, Samadi Kafil H, Aghazadeh M, Sheikhalizadeh V.
    Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.